The Fc portion of the IgG molecule is responsible fornon-specificbinding of human immunoglobulin of skeletal muscle. This binding can be reduced by using F(ab')2 fragments of IgG prepared by pepsin digestion (Aarli, 1970; Aarli and Closs, 1972) . For immunofluorescence, the use of conjugated pepsindigested immunoglobulin does not completely abolish staining due to non-specific binding of immunoglobulin.
SYNOPSIS
The binding of muscle antibodies to skeletal muscle was studied by immunofluorescence techniques. The non-specific fluorescence was not significantly reduced by absorption of the conjugate by tissue powder but was abolished by counterstaining with a 0-1 % Evans blue. Possible explanations for this effect are discussed. By this method, immunofluorescence may become more useful in the demonstration of muscle antibodies.
The Fc portion of the IgG molecule is responsible fornon-specificbinding of human immunoglobulin of skeletal muscle. This binding can be reduced by using F(ab')2 fragments of IgG prepared by pepsin digestion (Aarli, 1970; Aarli and Closs, 1972) . For immunofluorescence, the use of conjugated pepsindigested immunoglobulin does not completely abolish staining due to non-specific binding of immunoglobulin.
In attempts to localize a citric acid-soluble antigen in striated muscle, the presence of this nonspecific staining was a cause for concern. Nichols and McComb (1962) showed that counterstaining with Evans blue greatly reduced unwanted fluorescence in human conjunctival scrapings. The present paper describes the successful use of Evans blue in reducing non-specific fluorescence of skeletal muscle.
Materials and Methods

SERA
Sera from patients with myasthenia gravis were collected at the Department of Neurology. Normal human serum was obtained by collecting a pool of sera from blood donors.
Gamma globulin 165 % (AB Kabi, Stockholm, Sweden) was used as the source of human Ig in preparation of normal F(ab')2 fragments. Rabbit antiserum to human IgG was produced according to Larsen and Tonder (1969 (Lowry, Rosebrough, Farr, and Randall, 1951 The citric acid-soluble antigen (CAS) was prepared according to Espinosa and Kaplan (1968) . The antigen used in the blocking experiment had a protein content of 0 35 mg/ml and gave a haemagglutination inhibition titre of 2048 (Aarli, 1972a) .
INDIRECT HAEMAGGLUTINATION TEST FOR MUSCLE ANTIBODIES
This test was carried out as described by Aarli (1972a Similarly, with the indirect immunofluorescence technique, binding of myasthenia gravis 12 F(ab')2 fragments was inhibited when citric acid-soluble antigen was mixed with the fragments before use. The results of these blocking experiments indicated that the citric acid-soluble antigen was mainly responsible for specific binding of serum myasthenia gravis 12 to skeletal muscle and that this antigen is localized mainly in the sarcolemmal or subsarcolemmal region. A more detailed interpretation of these results is published elsewhere (Aarli, 1972b Counterstaining with Evans blue in order to reduce non-specific staining was first reported by Nichols and McComb (1962) . This method has since then been used successfully in a variety of immunofluorescence systems (Fry and Wilkinson, 1963; Boonpucknavig and Nairn, 1967; Ourth, 1971) . In the present experiments, counterstaining of the sections in 01 0% Evans blue effectively reduced the non-specific fluorescence due to binding of normal human IgG to skeletal muscle. Following this treatment no fluorescence was sern with normal sera at a magnification of 160 x At the highest magnification (1200 x ) some very weak fluorescence could also be observed with normal sera, but it appeared to be diffuse compared with the fluorescent pattern produced by patient sera. While there was a reduction in the overall intensity of the fluorescence produced by positive sera following the counterstaining procedure, the pattern of fluorescence changed from a diffuse to a distinctly localized one.
The effect of Evans blue may be produced in several ways. The dye may act as a filter absorbing a certain percentage of the excitation light or of the fluorescence emitted by FITC. The absorption spectrum of Evans blue is given in figure 3 preparation is seen against a red background. The colour recognized by the observer will depend on the intensity of green versus red fluorescence in each area. In areas with weak FITC fluorescence the red colour will dominate while strong FITC fluorescence will stand out sharply against the red background. By offering better colour contrast, Evans blue may enhance localization of the strongest and presumably most specific fluorescence. Finally, the dye may reduce non-specific staining by competing for the same structures on the muscle fibres that are responsible for the binding of immunoglobulins by their Fc portion.
In the present study sera from patients with myasthenia gravis produced fluorescence in the sarcolemmal or subsarcolemmal region and corresponding to the transverse striations of the muscle fibres. Blocking experiments indicated that the citric acid-soluble antigen is localized mainly in the sarcolemmal region. Sera which were strongly positive in IF also gave high titres in the indirect haemagglutination test with citric acid-soluble antigen. However, whereas only half of the patient sera were positive in the haemagglutination test, all were positive in immunofluorescence. The present modification of the immunofluorescence technique may therefore provide a useful test for the detection of muscle antibodies.
